Published in Blood Weekly, November 13th, 2003
Dr. Stassen spoke about a new embryonic stem (ES) cell culture medium developed by Thromb-X, NV, the research and development subsidiary of ThromboGenics, in Leuven, Belgium. The proprietary ES cell culture medium (called TX-WES), conditioned by a fibroblast cell line, allows derivation and maintenance of ES cell lines from all inbred mouse strains...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.